$CELZ: NEW UPDATED 03/26/18 DD PACKAGE~~A clinical
Post# of 103014
CLICK HERE TO VISIT THE CREATIVE MEDICAL TECHNOLOGY HOLDING, INC WEBSITE
ERECTILE DYSFUNCTION CLINICAL TRIALS
Why 2018 Could Be An Explosive Year For Biotech Mergers
https://www.investors.com/news/technology/why...h-mergers/
$11 billion biotech binge fuels forecasts of 2018 M&A surge
https://www.reuters.com/article/uk-biotech-m-...SKBN1EX1KF
Why 2018 is a make-or-break year for pharma
Many drugmakers have neglected their pipelines, and will look to acquisitions to bolster them
https://www.marketwatch.com/story/why-2018-is...2017-12-19
Tax Overhaul Could Jolt Dollar as U.S. Companies Bring Home Cash
Corporations could repatriate as much as $400 billion in earnings and cash from abroad
https://www.wsj.com/articles/tax-overhaul-cou...1514206800
CLICK HERE FOR MORE NEWS
Creative Medical Technology Holdings, Inc. To Unveil Its Patented CaverStem™ Procedure For Erectile Dysfunction At International Urology Conference
Press Release | 03/26/2018
Creative Medical Technology Holdings Licenses Intellectual Property from Internationally Renowned Neurologist and Creates Neurology Focused Stem Cell Subsidiary
Press Release | 02/20/2018
Stem Cells as Medicine: The Promise of Universal Donor Adult Stem Cells Continues to Attract Optimism
Press Release | 12/20/2017
"Urologist to the Stars" Dr. Alexander Gershman Begins Treating Patients with Patented Caverstem™ Stem Cell Procedure for Drug Refractory Erectile Dysfunction
Press Release | 12/18/2017
Creative Medical Technology Holdings Recruits Top Urologists for Caverstem™ Stem Cell Treatment of Erectile Dysfunction
Press Release | 12/14/2017